BBIO
BridgeBio Pharma, Inc.
Set alert
74.95 USD +4.22 +5.97%
71.91 Day range 75.65
61.37 52-week range 90.17
- YTD
- -2.01%
- 1 year
- +18.27%
- Open
- 72.85
- Prev close
- 70.73
- Mkt cap
- 14.65B
- Vol
- 5.77M
- Avg vol
- 2.52M
- EPS
- -3.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 71.91
- High
- 75.65
- Forward P/E
- -333.67
- Beta
- 0.97
- Short ratio
- 6.50
- Inst. own
- 99.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 70.43
- 200-d avg
- 72.76
- 1y target
- 107.81
1Y chart
Closing price and volume
Compare BBIO
Chart and line up BBIO against other symbols or a saved comparison set.
- BBIO BridgeBio Pharma, Inc.
74.95
+4.22 +5.97%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | BBIO | SPY | QQQ |
|---|---|---|---|
| Last price | 74.95 | 755.72 | 690.49 |
| Change | +4.22 | -13.64 | -24.85 |
| Change % | +5.97% | -1.77% | -3.47% |
| Open | 72.85 | 761.38 | 697.13 |
| Day high | 75.65 | 761.46 | 698.63 |
| Day low | 71.91 | 750.36 | 683.45 |
| Previous close | 70.73 | 769.36 | 715.34 |
| Volume | 5.77M | 77.70M | 85.24M |
| Average volume | 2.52M | 41.22M | 34.57M |
| Market cap | 14.65B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -3.56 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 90.17 | 779.09 | 759.66 |
| 52-week low | 61.37 | 631.97 | 558.28 |
| 1-week return | +9.32% | -0.559233% | -1.97% |
| 1-month return | +13.91% | -0.906075% | -6.66% |
| 3-month return | -8.75% | +1.89% | +1.02% |
| 6-month return | +5.40% | +5.16% | +3.41% |
| Year-to-date return | -2.01% | +10.82% | +12.40% |
| 1-year return | +18.27% | +11.16% | +10.29% |
| 2-year return | +220.16% | +32.90% | +42.71% |
| 50-day moving average | 70.43 | 767.63 | 725.41 |
| 200-day moving average | 72.76 | 728.53 | 679.17 |
| Target price | 107.81 | — | — |
| Beta | 0.972 | 0.00 | 0.00 |
| Short ratio | 6.50 | — | — |
| Institutional ownership | 99.55% | — | — |